Norman Payson - Oct 27, 2021 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Director
Signature
/s/ Jennifer Bealer, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
Oct 27, 2021
Transactions value $
-$1,006,988
Form type
4
Date filed
10/29/2021, 04:46 PM
Previous filing
Oct 26, 2021
Next filing
Nov 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Sale -$475K -7.83K -1.19% $60.65 648K Oct 27, 2021 See footnote F1, F2, F3, F4
transaction PGNY Common Stock Sale -$30.9K -504 -0.08% $61.30 647K Oct 27, 2021 See footnote F1, F3, F4, F5
transaction PGNY Common Stock Sale -$256K -4.28K -0.66% $59.76 643K Oct 28, 2021 See footnote F1, F3, F6
transaction PGNY Common Stock Sale -$246K -4.05K -0.63% $60.66 639K Oct 28, 2021 See footnote F1, F3, F4, F7
holding PGNY Common Stock 122K Oct 27, 2021 See footnote F8
holding PGNY Common Stock 8.65K Oct 27, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 21, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.99 to $60.98, inclusive.
F3 The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6) and (7).
F4 The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.0 to $61.4 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.18 to $60.09 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.19 to $61.11 inclusive.
F8 The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.